164 related articles for article (PubMed ID: 34323589)
21. The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers.
Vreemann S; Gubern-Mérida A; Borelli C; Bult P; Karssemeijer N; Mann RM
PLoS One; 2018; 13(1):e0191399. PubMed ID: 29351560
[TBL] [Abstract][Full Text] [Related]
22. Comparison of background parenchymal enhancement (BPE) on contrast-enhanced cone-beam breast CT (CE-CBBCT) and breast MRI.
Ma Y; Liu A; Zhang Y; Zhu Y; Wang Y; Zhao M; Liang Z; Qu Z; Yin L; Lu H; Ye Z
Eur Radiol; 2022 Aug; 32(8):5773-5782. PubMed ID: 35320411
[TBL] [Abstract][Full Text] [Related]
23. Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study.
Watt GP; Sung J; Morris EA; Buys SS; Bradbury AR; Brooks JD; Conant EF; Weinstein SP; Kontos D; Woods M; Colonna SV; Liang X; Stein MA; Pike MC; Bernstein JL
Breast Cancer Res; 2020 Dec; 22(1):138. PubMed ID: 33287857
[TBL] [Abstract][Full Text] [Related]
24. Background parenchymal enhancement over exam time in patients with and without breast cancer.
Melsaether A; Pujara AC; Elias K; Pysarenko K; Gudi A; Dodelzon K; Babb JS; Gao Y; Moy L
J Magn Reson Imaging; 2017 Jan; 45(1):74-83. PubMed ID: 27285396
[TBL] [Abstract][Full Text] [Related]
25. MRI of the Lactating Breast: Computer-Aided Diagnosis False Positive Rates and Background Parenchymal Enhancement Kinetic Features.
Nissan N; Sorin V; Bauer E; Anaby D; Samoocha D; Yagil Y; Faermann R; Halshtok-Neiman O; Shalmon A; Gotlieb M; Sklair-Levy M
Acad Radiol; 2022 Sep; 29(9):1332-1341. PubMed ID: 34857455
[TBL] [Abstract][Full Text] [Related]
26. Quantitative evaluation of Kaiser score in diagnosing breast dynamic contrast-enhanced magnetic resonance imaging for patients with high-grade background parenchymal enhancement.
Wang H; Gao L; Chen X; Wang SJ
Quant Imaging Med Surg; 2023 Oct; 13(10):6384-6394. PubMed ID: 37869283
[TBL] [Abstract][Full Text] [Related]
27. The Association of Background Parenchymal Enhancement at Breast MRI with Breast Cancer: A Systematic Review and Meta-Analysis.
Thompson CM; Mallawaarachchi I; Dwivedi DK; Ayyappan AP; Shokar NK; Lakshmanaswamy R; Dwivedi AK
Radiology; 2019 Sep; 292(3):552-561. PubMed ID: 31237494
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging.
Sogani J; Morris EA; Kaplan JB; D'Alessio D; Goldman D; Moskowitz CS; Jochelson MS
Radiology; 2017 Jan; 282(1):63-73. PubMed ID: 27379544
[TBL] [Abstract][Full Text] [Related]
29. Ultrafast Dynamic Contrast-Enhanced Breast MRI: Lesion Conspicuity and Size Assessment according to Background Parenchymal Enhancement.
Kim SY; Cho N; Choi Y; Shin SU; Kim ES; Lee SH; Chang JM; Moon WK
Korean J Radiol; 2020 May; 21(5):561-571. PubMed ID: 32323501
[TBL] [Abstract][Full Text] [Related]
30. Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI.
King V; Gu Y; Kaplan JB; Brooks JD; Pike MC; Morris EA
Eur Radiol; 2012 Dec; 22(12):2641-7. PubMed ID: 22752463
[TBL] [Abstract][Full Text] [Related]
31. Repeated surgeries in invasive lobular breast cancer with preoperative MRI: Role of additional carcinoma in situ and background parenchymal enhancement.
Preibsch H; Richter V; Bahrs SD; Hattermann V; Wietek BM; Bier G; Kloth C; Blumenstock G; Hahn M; Staebler A; Nikolaou K; Wiesinger B
Eur J Radiol; 2017 May; 90():181-187. PubMed ID: 28583631
[TBL] [Abstract][Full Text] [Related]
32. Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program : A retrospective cohort study.
Vreemann S; Dalmis MU; Bult P; Karssemeijer N; Broeders MJM; Gubern-Mérida A; Mann RM
Eur Radiol; 2019 Sep; 29(9):4678-4690. PubMed ID: 30796568
[TBL] [Abstract][Full Text] [Related]
33. Inter- and intrareader agreement for categorization of background parenchymal enhancement at baseline and after training.
Melsaether A; McDermott M; Gupta D; Pysarenko K; Shaylor SD; Moy L
AJR Am J Roentgenol; 2014 Jul; 203(1):209-15. PubMed ID: 24951217
[TBL] [Abstract][Full Text] [Related]
34. Quantitative analysis of background parenchymal enhancement in whole breast on MRI: Influence of menstrual cycle and comparison with a qualitative analysis.
Jung Y; Jeong SK; Kang DK; Moon Y; Kim TH
Eur J Radiol; 2018 Jun; 103():84-89. PubMed ID: 29803391
[TBL] [Abstract][Full Text] [Related]
35. MRI can accurately diagnose breast cancer during lactation.
Nissan N; Massasa EEM; Bauer E; Halshtok-Neiman O; Shalmon A; Gotlieb M; Faermann R; Samoocha D; Yagil Y; Ziv-Baran T; Anaby D; Sklair-Levy M
Eur Radiol; 2023 Apr; 33(4):2935-2944. PubMed ID: 36348090
[TBL] [Abstract][Full Text] [Related]
36. Multiparametric
Leithner D; Helbich TH; Bernard-Davila B; Marino MA; Avendano D; Martinez DF; Jochelson MS; Kapetas P; Baltzer PAT; Haug A; Hacker M; Tanyildizi Y; Morris EA; Pinker K
J Nucl Med; 2020 Jan; 61(1):20-25. PubMed ID: 31253745
[TBL] [Abstract][Full Text] [Related]
37. Quantitative background parenchymal enhancement and fibro-glandular density at breast MRI: Association with BRCA status.
Goodburn R; Kousi E; Sanders C; Macdonald A; Scurr E; Bunce C; Khabra K; Reddy M; Wilkinson L; O'Flynn E; Allen S; Schmidt MA
Eur Radiol; 2023 Sep; 33(9):6204-6212. PubMed ID: 37017702
[TBL] [Abstract][Full Text] [Related]
38. Background parenchymal enhancement on breast MRI: association with recurrence-free survival in patients with newly diagnosed invasive breast cancer.
Lim Y; Ko ES; Han BK; Ko EY; Choi JS; Lee JE; Lee SK
Breast Cancer Res Treat; 2017 Jun; 163(3):573-586. PubMed ID: 28349273
[TBL] [Abstract][Full Text] [Related]
39. Fully automatic quantification of fibroglandular tissue and background parenchymal enhancement with accurate implementation for axial and sagittal breast MRI protocols.
Wei D; Jahani N; Cohen E; Weinstein S; Hsieh MK; Pantalone L; Kontos D
Med Phys; 2021 Jan; 48(1):238-252. PubMed ID: 33150617
[TBL] [Abstract][Full Text] [Related]
40. Preliminary analysis: Background parenchymal 18F-FDG uptake in breast cancer patients appears to correlate with background parenchymal enhancement and to vary by distance from the index cancer.
Kim E; Mema E; Axelrod D; Sigmund E; Kim SG; Babb J; Melsaether AN
Eur J Radiol; 2019 Jan; 110():163-168. PubMed ID: 30599855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
